Carrascosa JM - Search Results

1

Use of off-label doses is frequent in biologic therapy for moderate to severe psoriasis: A cross-sectional study in clinical practice.

Carrascosa JM, Garcia-Doval I, Pérez-Zafrilla B, Carretero G, Vanaclocha F, Daudén E, De la Cueva-Dobao P, Belinchón I, Alsina M, López-Estebaranz JL, Ferrán M, Torrado R, Rivera R, Carazo C, Barboza L, Ferrándiz C; BIOBADADERM Study Group. Carrascosa JM, et al. J Dermatolog Treat. 2015;26(6):502-6. doi: 10.3109/09546634.2015.1034070. Epub 2015 Apr 17. J Dermatolog Treat. 2015. PMID: 25886087

2

Cutis marmorata telangiectatica congenita or neonatal lupus?

Carrascosa JM, Ribera M, Bielsa I, Coroleu W, Ferrándiz C. Carrascosa JM, et al. Pediatr Dermatol. 1996 May-Jun;13(3):230-2. doi: 10.1111/j.1525-1470.1996.tb01209.x. Pediatr Dermatol. 1996. PMID: 8806125

3

Sequential combined therapy with thalidomide and narrow-band (TL01) UVB in the treatment of prurigo nodularis.

Ferrándiz C, Carrascosa JM, Just M, Bielsa I, Ribera M. Ferrándiz C, et al. Among authors: carrascosa jm. Dermatology. 1997;195(4):359-61. doi: 10.1159/000245988. Dermatology. 1997. PMID: 9529557 Clinical Trial.

4

Papular acrodermatitis of childhood related to poxvirus and parvovirus B19 infection.

Carrascosa JM, Just M, Ribera M, Ferrándiz C. Carrascosa JM, et al. Cutis. 1998 May;61(5):265-7. Cutis. 1998. PMID: 9608338

5

An immunohistopathologic study in cutaneous necrotizing vasculitis.

Bielsa I, Carrascosa JM, Hausmann G, Ferrándiz C. Bielsa I, et al. Among authors: carrascosa jm. J Cutan Pathol. 2000 Mar;27(3):130-5. doi: 10.1034/j.1600-0560.2000.027003130.x. J Cutan Pathol. 2000. PMID: 10728815

6

A prospective evaluation of the cost of psoriasis in Spain (EPIDERMA project: phase II).

Carrascosa JM, Pujol R, Daudén E, Hernanz-Hermosa JM, Bordas X, Smandia JA, Ferrándiz C. Carrascosa JM, et al. J Eur Acad Dermatol Venereol. 2006 Aug;20(7):840-5. doi: 10.1111/j.1468-3083.2006.01659.x. J Eur Acad Dermatol Venereol. 2006. PMID: 16898908

7

Managing moderate-to-severe psoriasis with efalizumab: experience at a single Spanish institute.

Ferrándiz C, Carrascosa JM. Ferrándiz C, et al. Among authors: carrascosa jm. Br J Dermatol. 2007 Apr;156 Suppl 2:24-9. doi: 10.1111/j.1365-2133.2007.07766.x. Br J Dermatol. 2007. PMID: 17371320

8

Effective management of a psoriatic flare with narrowband UVB phototherapy during efalizumab therapy without discontinuing treatment.

Carrascosa JM, Soria X, Ferrándiz C. Carrascosa JM, et al. J Eur Acad Dermatol Venereol. 2007 Jul;21(6):828-9. doi: 10.1111/j.1468-3083.2006.01970.x. J Eur Acad Dermatol Venereol. 2007. PMID: 17567319 No abstract available.

9

Allergic contact dermatitis to 2(thiocyano-methylthio) benzothiazole present in a packaging wood.

Domingo H, Carrascosa JM, Boada A, Leal L, Ferrándiz C. Domingo H, et al. Among authors: carrascosa jm. Contact Dermatitis. 2007 Aug;57(2):121-2. doi: 10.1111/j.1600-0536.2006.01052.x. Contact Dermatitis. 2007. PMID: 17627655 No abstract available.

10

Effects of narrowband UV-B on pharmacodynamic markers of response to therapy: an immunohistochemical study over sequential samples.

Carrascosa JM, Tapia G, Bielsa I, Fuente MJ, Ferrandiz C. Carrascosa JM, et al. J Cutan Pathol. 2007 Oct;34(10):769-76. doi: 10.1111/j.1600-0560.2006.00694.x. J Cutan Pathol. 2007. PMID: 17880582

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

325 results

Search Page